NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Sep 2019
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 12h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Potassium Phosphates is an intravenous solution containing dibasic and monobasic potassium phosphate salts used to correct phosphate and potassium deficiencies in hospitalized patients. This electrolyte replacement therapy addresses critical mineral imbalances that can impair cellular function and organ systems. The product works by directly supplementing serum phosphate and potassium levels in patients unable to maintain adequate nutrition or those with depleted stores.
Peak12.4 years to LOE
As a hospital-based IV electrolyte product at peak lifecycle, this supports a stable specialty pharmacy and hospital systems team focused on formulary management and clinical outcomes.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Potassium Phosphates offers career stability in a niche, defensible market segment with minimal competition and a long patent runway. This product provides solid foundational experience in hospital systems, formulary management, and specialty pharma operations without the volatility of high-competition therapeutic areas.
Hospital Account ManagerSpecialty Pharmacy Sales Representative
Worked on POTASSIUM PHOSPHATES at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.